DTL
ADCT icon

Dynamic Technology Lab’s ADC Therapeutics ADCT Stock Holding History

Dynamic Technology Lab’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-43,970
Closed -$165K – 642
2026
Q1 		$165K Buy
+43,970
New +$173K 0.03% 759
2023
Q2 		– Sell
-14,332
Closed -$28K – 951
2023
Q1 		$28K Buy
+14,332
New +$52.9K ﹤0.01% 1015
2022
Q4 		– Sell
-16,957
Closed -$82K – 1047
2022
Q3 		$82K Buy
+16,957
New +$123K 0.01% 1037

Other funds holding ADCT

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dynamic Technology Lab's ADCT Position: Q2 2026 in Review

Dynamic Technology Lab sold out of ADC Therapeutics (ADCT) in Q2 2026, closing a stake of 43,970 shares — an estimated $165K sold.

Dynamic Technology Lab first reported a position in ADCT in Q3 2022 and held it in 3 quarters. The position peaked at $165K in Q1 2026. 114 funds tracked by Wall St. Rank hold ADCT as of Q2 2026.

  • Dynamic Technology Lab reported no remaining ADC Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Dynamic Technology Lab sold 43,970 ADC Therapeutics shares in Q2 2026, an estimated $165K.
  • Dynamic Technology Lab first reported a position in ADC Therapeutics in Q3 2022 and held it in 3 quarters.
  • Dynamic Technology Lab's ADC Therapeutics position peaked at $165K in Q1 2026.
  • 114 funds tracked by Wall St. Rank held ADC Therapeutics as of Q2 2026.

Based on Dynamic Technology Lab's 13F filing for Q2 2026, filed 13 Aug 2026.